Publication

Stolze LK, Conklin AC, Whalen MB, López Rodríguez M, Õunap K, Selvarajan I, Toropainen A, Örd T, Li J, Eshghi A, et al. 2020. Systems Genetics in Human Endothelial Cells Identifies Non-coding Variants Modifying Enhancers, Expression, and Complex Disease Traits. Am J Hum Genet. 106:748–763. doi:10.1016/j.ajhg.2020.04.008.

Turner DL, Korneev DV, Purdy JG, de Marco A, Mathias RA. 2020. The host exosome pathway underpins biogenesis of the human cytomegalovirus virion. Elife. 9. doi:10.7554/eLife.58288.

Rajan SS, Amin AD, Li L, Rolland DC, Li H, Kwon D, Kweh MF, Arumov A, Roberts ER, Yan A, et al. 2020. The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma. Oncogene. 39:2103–2117. doi:10.1038/s41388-019-1136-4.

Gowin K, Langlais BT, Kosiorek HE, Dueck A, Millstine D, Huberty J, Eckert R, Mesa RA. 2020. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms. Cancer Med. 9:9445–9453. doi:10.1002/cam4.3566.

Uhlorn BL, Jackson R, Li S, Bratton SM, Van Doorslaer K, Campos SK. 2020. Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection. PLoS Pathog. 16:e1009028. doi:10.1371/journal.ppat.1009028.

Cunningham JK, Ritchey J, Arambula Solomon TG. 2020. With socioeconomic status controlled, cigarette use is lower among American Indians/Alaska Natives than whites. Drug Alcohol Depend. 211:107836. doi:10.1016/j.drugalcdep.2020.107836.

Pandey R, Zhou M, Islam S, Chen B, Barker NK, Langlais P, Srivastava A, Luo M, Cooke LS, Weterings E, et al. 2019. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target. Sci Rep. 9:18347. doi:10.1038/s41598-019-54545-9.

Park CK, Horton NC. 2019. Structures, functions, and mechanisms of filament forming enzymes: a renaissance of enzyme filamentation. Biophys Rev. 11:927–994. doi:10.1007/s12551-019-00602-6.

Krummel M, Blish C, Kuhns M, Cadwell K, Oberst A, Goldrath A, Ansel KM, Chi H, O’Connell R, Wherry EJ, et al. 2019. Universal Principled Review: A Community-Driven Method to Improve Peer Review. Cell. 179:1441–1445. doi:10.1016/j.cell.2019.11.029.

Buetow KH, Meador LR, Menon H, Lu Y-K, Brill J, Cui H, Roe DJ, DiCaudo DJ, Hastings KT. 2019. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma. The Journal of Immunology. 203(10):2577–2587. doi:10.4049/jimmunol.1900476.

Borden ES, Kang P, Natri HM, Phung TN, Wilson MA, Buetow KH, Hastings KT. 2019. Neoantigen Fitness Model Predicts Lower Immune Recognition of Cutaneous Squamous Cell Carcinomas Than Actinic Keratoses. Frontiers in Immunology. 10. doi:10.3389/fimmu.2019.02799.

Michel‐Ramirez G, Recio‐Vega R, Lantz RC, Gandolfi AJ, Olivas‐Calderon E, Chau BT, Amistadi MK. 2019. Assessment of YAP gene polymorphisms and arsenic interaction in Mexican women with breast cancer. Journal of Applied Toxicology. 40(3):342–351. doi:10.1002/jat.3907.

Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. 2019. Epigenetic Activation of by Genistein In Vivo and Triple Negative Breast Cancer Cells Linked to Antagonism toward Aryl Hydrocarbon Receptor. Nutrients. 11. doi:10.3390/nu11112559.

Chen H, Sells E, Pandey R, Abril ER, Hsu C-H, Krouse RS, Nagle RB, Pampalakis G, Sotiropoulou G, Ignatenko NA. 2019. Kallikrein 6 protease advances colon tumorigenesis induction of the high mobility group A2 protein. Oncotarget. 10:6062–6078. doi:10.18632/oncotarget.27153.

Jameson GS, Borazanci E, Babiker HM, Poplin E, Niewiarowska AA, Gordon MS, Barrett MT, Rosenthal A, Stoll-D’Astice A, Crowley J, et al. 2019 Oct. Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial. JAMA Oncol. doi:10.1001/jamaoncol.2019.3394.

Cunningham JK, Ritchey J, Solomon TA, Cordova FM. 2019. Cigarette Use Among American Indians and Alaska Natives in Metropolitan Areas, Rural Areas, and Tribal Lands. J Public Health Manag Pract. 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years:S11-S19. doi:10.1097/PHH.0000000000001026.

Alvarado C, Stahl E, Koessel K, Rivera A, Cherry BR, Pulavarti SVSRK, Szyperski T, Cance W, Marlowe T. 2019. Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR. Molecules. 24. doi:10.3390/molecules24183352.

Babiker HM, Davis L, Larson K, Placencia C, Swensen C, Tenneti P, Lim M, Cañamar R, Curtis J, Castillo E, et al. 2019. A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations. Expert Opin Investig Drugs. 28:675–686. doi:10.1080/13543784.2019.1646726.

Kostelic MM, Ryan AM, Reid DJ, Noun JM, Marty MT. 2019. Expanding the Types of Lipids Amenable to Native Mass Spectrometry of Lipoprotein Complexes. J Am Soc Mass Spectrom. 30:1416–1425. doi:10.1007/s13361-019-02174-x.

Ganguly SS, Hostetter G, Tang L, Frank SB, Saboda K, Mehra R, Wang L, Li X, Keller ET, Miranti CK. 2019. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3. Oncogene. 39(1):204–218. doi:10.1038/s41388-019-0977-1.

Nair US, Reikowsky RC, Allen AM, Bell ML. 2019. Quitline program utilization and cessation outcomes: A comparison of provider-referred clients by healthcare settings. Prev Med Rep. 14:100863. doi:10.1016/j.pmedr.2019.100863.

Pandey R, Woo H-H, Varghese F, Zhou M, Chambers SK. 2019. Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer. Transl Oncol. 12:714–725. doi:10.1016/j.tranon.2019.01.006.

Song JH, Kang H-J, Luevano LA, Gokhale V, Wu K, Pandey R, Chow H-HS, Hurley LH, Kraft AS. 2019 May. Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death. Cell Chem Biol. doi:10.1016/j.chembiol.2019.04.009.

Burt PM, Xiao L, Doetschman T, Hurley MM. 2019. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection. J Cell Physiol. 234:4418–4431. doi:10.1002/jcp.27230.

Arrington AK, Price ET, Golisch K, Riall TS. 2019. Pancreatic Cancer Lymph Node Resection Revisited: A Novel Calculation of Number of Lymph Nodes Required. Journal of the American College of Surgeons. 228(4):662–669.